In a new €400 million Investment a US Pharmaceutical Company expects to Create 300 Jobs

Eli Lilly, a large US pharmaceutical Company, has revealed intentions to invest €400 million in a huge new manufacturing factory in Limerick, which will employ 300 people when it opens.The firm is now in discussions concerning the IDA Ireland sites planning. It plans to begin building later this year, with a planned opening date of late 2025/early 2026.Edgardo Hernandez, the Company head of manufacturing, stated that recruiting will begin immediately.

When asked about planning challenges and the security of power and water supplies, which have been raised in the wake of Intel’s choice to locate a facility in Germany rather than Ireland, Mr. Hernandez said the business had conducted a worldwide review of locales before deciding on Limerick.Eli Lilly already has a large presence in Ireland, with a manufacturing factory in Kinsale, Co Cork, and a business centre at Little Island, also in Cork.

In addition, it operates contract manufacturing facilities in the state.”We’ve continued to invest in Ireland for the past 40 years in part because of supporting government policies that promote life science research,” Mr. Hernandez added. “We will be able to enhance our ability to manufacture creative new medicines that can help cure some of the world’s most critical conditions” at the new Lilly facility in Limerick.

Eli Lilly is now working on a therapy for Alzheimer’s disease that has high hopes. The business has completed enrollment in a phase III trial for the medicine Donanemab, which will examine its efficacy in preventing disease progression.The results of that experiment will be published next year, and they will inform the Company current discussions with US authorities over the medicine’s clearance.